IDN Key Account Executive II - Chicago, IL

Sorry, this job was removed at 08:18 p.m. (UTC) on Thursday, Jan 22, 2026
Be an Early Applicant
Chicago, IL, USA
In-Office
119K-155K Annually
Biotech
The Role
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect the world against infectious diseases. We operate with the highest level of quality, integrity and safety for the betterment of public health. Our proprietary CpG 1018 adjuvant powers our diversified infectious vaccine portfolio, which includes HEPLISAV-B®, our commercial product approved in the U.S. and the European Union, for prevention of hepatitis B virus in adults. We also supply CpG 1018 to research collaborations and partnerships globally. Currently, CpG 1018 is being used in development of COVID-19, plague, shingles, and Tdap vaccines. 
 
At Dynavax, our vision and work ethic are guided by the collective ideals underpinning our core values, and these form the basis of our dynamic company culture. We strive to maintain a culture where each employee is valued by the organization and where our organization is valued by each employee. We offer a highly flexible work environment for our headquarter employees where individuals work remotely and gather for in-person meetings when necessary.  Dynavax is headquartered in the San Francisco Bay area, and our manufacturing facility is in Düsseldorf, Germany.  

The IDN Key Account Executive II will have full account responsibility and business ownership for assigned Accounts to establish and grow HEPLISAV-B sales.  Working with the Director, Vaccine Sales this position will serve as the primary account owner with assigned IDN, Independent and Group Practice accounts.  The IDN Key Account Executive II will be responsible for full top down and bottom up ownership and execution in assigned accounts with a primary objective of expanding Adult Hepatitis B Vaccination and greater adoption of HEPLISAV-B.  This role will be responsible for understanding sales strategies and execution plans that enable HEPLISAV-B to meet its full revenue potential in assigned accounts. The IDN Key Account Executive II position will be expected to execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements.  This position is field based and will require daily travel. The ideal candidate should reside in or near Chicago, but other locations in major metropolitan areas within the assigned territory will be considered.

Responsibilities

  • Responsible for achieving sales targets and owning/managing customer relationships for assigned Accounts.  Assigned accounts will include large IDNs, independent customers and group practices.
  • Serves as sole owner for assigned accounts – responsible for successful execution at all levels of the customer organization to achieve declared goals/objectives.
  • Demonstrates a deep understanding of vaccine decision making, vaccine adoption and implementation process and key decision makers across all levels of assigned accounts.
  • Responsible for developing, communicating, and monitoring an account strategy for each assigned account.  Conducts quarterly business reviews with Director, Vaccine Sales.
  • Execute all functions of the role independently with minimal supervision from the Director, Vaccine Sales and/or assigned mentor for executive level customer engagements. 
  • Develop relationships with key stakeholders at each level of organization who are responsible for implementation of vaccines. 
  • Partner with Director, Vaccine Sales to execute sales & marketing strategies to support HEPLISAV-B expansion within assigned accounts.
  • Responsible for understanding competitive positioning, market dynamics and customer business models to identify opportunities across assigned accounts.
  • Maintain accurate up-to-date customer records in the Account Management system.
  • Exercise sound judgement and oversight to ensure integrity and compliance with company policies in all activities and communications.
  • Foster Dynavax core values and leadership behaviors.
  • Other duties as assigned.

Qualifications

  • Bachelor’s Degree required from an accredited institution; MBA preferred.
  • 3+ years of life sciences sales experience required; IDN/Hospital experience preferred.
  • 2 years of vaccine or buy & bill experience required.
  • 2+ years of strategic account management experience preferred.
  • Knowledge of the IDN/Hospital landscape within assigned territory required.
  • Previous health system account management experience is highly preferred.
  • Strong proven strategic vision, business acumen and influencing skills to drive strategic and operational initiatives across the organization.
  • Documented track record of consistent sales and growth success along with superb account management skills.
  • Proven track record of financial/budget management experience.
  • Knowledge of large health systems, including immunization related quality initiatives.
  • Excellent oral and written communication skills, presentation and influencing skills.
  • Ability to drive business results and identify new opportunities and strategies through strategic thinking and business planning.
  • Experience in matrix management, change advocate.
  • Heavy travel required.
  • Key Competencies:  Accountability, Customer Engagement, Customer Discovery, Business Acumen, Executional Effectiveness
  • Ability to operate a motor vehicle.
  • Ability to sit for prolonged periods; reach with arms and hands; lift and move small objects; and use hands to keyboard and perform other office related tasks including repetitive movement of the wrists, hands and/or fingers.
  • Must be able to obtain all industry credentials and certifications.

  • Additional Knowledge and Skills desired, but not required:
  • C-suite leadership and account management experience within IDNs and Hospitals is highly preferred.

California residents: for information on how we handle your personal information and your privacy rights as a job candidate, please see our Candidate Privacy Notice: https://www.dynavax.com/file.cfm/53/docs/dynavax_privacy_notice_for_california_applicants.pdf

Dynavax is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status.

Similar Jobs

Boeing Logo Boeing

Executive Assistant

Aerospace • Information Technology • Software • Cybersecurity • Design • Defense • Manufacturing
In-Office
Chicago, IL, USA
170000 Employees
82K-120K Annually

Morningstar Logo Morningstar

Talent Acquisition Scheduling Coordinator (6-month contract)

Artificial Intelligence • Big Data • Enterprise Web • Fintech • Software • Financial Services
Hybrid
Chicago, IL, USA
11500 Employees
100-500 Hourly

BlackRock Logo BlackRock

Director, Business & Platform Development, US Direct

Fintech • Information Technology • Financial Services
In-Office
5 Locations
25000 Employees
185K-270K Annually

Optum Logo Optum

Float Pharmacist - Community Pharmacy

Artificial Intelligence • Big Data • Healthtech • Information Technology • Machine Learning • Software • Analytics
In-Office
Chicago, IL, USA
160000 Employees
44-79 Hourly
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Emeryville, CA
319 Employees

What We Do

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S. and the European Union for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older, and CpG 1018 adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant through global research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, seasonal influenza, universal influenza, plague, shingles and Tdap. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn. Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, martial and veteran status.

Similar Companies Hiring

Formation Bio Thumbnail
Artificial Intelligence • Big Data • Healthtech • Biotech • Pharmaceutical
New York, NY
150 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account